Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Learn which credit cards provide the best reward points and how to maximize their value. Enhance your rewards strategy.
28,145 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
When a CEO sells thousands of shares, investors want to know what it signals. This guide explains how to read insider...
Marvell Technology climbs as Wall Street shifts to a more favorable view after closing the XConn deal, with price tar...
Silver isn’t just a shiny metal—it’s a complex mix of industrial demand and investor sentiment. This article breaks d...
A new AI-focused ETF from Wedbush-backed manager Dan Ives is drawing attention for its blend of megacap AI leaders an...
Mercer International posts a brutal Q4 hit from impairment, eroding equity, while International Paper pivots to highe...
With Trump heading to China for high-stakes talks, Goldman Sachs flags a dollar overvaluation of roughly 12-15% versu...
Google’s Gemini AI signals a potential XRP rally by late June 2026, citing two concrete regulatory moves as catalysts...
Britain’s Financial Conduct Authority added Hyperliquid and the Hyper Foundation to its warning list on May 21, citin...
Investors are re-evaluating JEPI after peers showed stronger upside. This report breaks down the real costs behind JE...
Amazon unveils a $25 billion bond tranche to accelerate AWS growth and custom silicon, highlighting a silicon-first p...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...